Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy.
Wexler
R R
RR
DuPont Merck Pharmaceutical Company, Wilmington, Delaware, USA.
Greenlee
W J
WJ
Irvin
J D
JD
Goldberg
M R
MR
Prendergast
K
K
Smith
R D
RD
Timmermans
P B
PB
D057911:Angiotensin Receptor Antagonists; D000818:Animals; D000959:Antihypertensive Agents / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D011945:Receptors, Angiotensin / Q000145:classification; D013329:Structure-Activity Relationship
D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D011945:Receptors, Angiotensin